Lymphoma, includes administration of radiopharmaceutical (e.g., radiolabeled antibodies) radiopharmaceutical biodistribution, single or multiple scans on one or more days, pre-treatment planning for radiopharmaceutical therapy of non-hodgkin's
This is the 2006 version of HCPCS G0273 - please refer to the 2016 HCPCS code set for the latest version.
